A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma

被引：0
|
作者：
Trefzer, U
Weingart, G
Chen, Y
Adrian, K
Audring, H
Winter, H
Guo, YJ
Sterry, W
Walden, P
机构：
[1] Humboldt Univ, Fac Med Charite, Dept Dermatol, D-10098 Berlin, Germany
[2] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA
来源：
GENE THERAPY OF CANCER | 1998年 / 451卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：519 / 525
页数：7
相关论文
共 50 条
  • [41] A PHASE I, II TRIAL OF AUTOLOGOUS DENDRITIC CELL TUMOR VACCINE COMBINED WITH IRRADIATION PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER
    Choi, Y. J.
    Seol, Y. M.
    Kim, H. J.
    Chung, J. S.
    Cho, G. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 172 - 172
  • [42] Phase I trial of ImmunoBody in melanoma patients.
    Patel, Poulam M.
    Durrant, Lindy G.
    Ottensmeier, Christian
    Mulatero, Clive
    Lorigan, Paul
    Plummer, Ruth
    Cunnell, Michelle
    Metheringham, Rachael
    Brentville, Victoria
    Machado, Lee
    Daniels, Ian
    Hannaman, Drew
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] Treatment of patients with malignant melanoma with a hybrid cell vaccine.
    Trefzer, U
    Weingart, G
    Adrian, K
    Guo, YJ
    Winter, H
    Walden, P
    Sterry, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 41 - 41
  • [44] Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
    Oshita, Chie
    Takikawa, Masako
    Kume, Akiko
    Miyata, Haruo
    Ashizawa, Tadashi
    Iizuka, Akira
    Kiyohara, Yoshio
    Yoshikawa, Shusuke
    Tanosaki, Ryuji
    Yamazaki, Naoya
    Yamamoto, Akifumi
    Takesako, Kazutoh
    Yamaguchi, Ken
    Akiyama, Yasuto
    ONCOLOGY REPORTS, 2012, 28 (04) : 1131 - 1138
  • [45] A Phase I study of temozolomide and carboplatin in patients with metastatic melanoma
    Strauss, SJ
    Marples, M
    Meyer, T
    Napier, M
    Boxall, J
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2001, 85 : 51 - 51
  • [46] Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
    Weber, Jeffrey S.
    O'Day, Steven
    Urba, Walter
    Powderly, John
    Nichol, Geoff
    Yellin, Michael
    Snively, Jolie
    Hersh, Evan
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 5950 - 5956
  • [47] Initial Results of a Phase I andII: A trial of Tumor Lysate Particle Loaded Dendritic Cell (TLPLDC) Vaccine Combined with Checkpoint Inhibitors in Metastatic Melanoma
    Myers, J. W.
    Clifton, G. T.
    Vreeland, T. J.
    Brown, T. A.
    Peace, K. M.
    Greene, J. M.
    Jackson, D. O.
    Hale, D. F.
    Berry, J. S.
    O'Day, S. J.
    Peoples, G. E.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S180 - S180
  • [48] Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
    Michael G. E. O'Rourke
    Maree Johnson
    Catherine Lanagan
    Janet See
    Jie Yang
    John R. Bell
    Greg J. Slater
    Beverley M. Kerr
    Beth Crowe
    David M. Purdie
    Suzanne L. Elliott
    Kay A. O. Ellem
    Christopher W. Schmidt
    Cancer Immunology, Immunotherapy, 2003, 52 : 387 - 395
  • [49] Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
    O'Rourke, MGE
    Johnson, M
    Lanagan, C
    See, J
    Yang, J
    Bell, JR
    Slater, GJ
    Kerr, BM
    Crowe, B
    Purdie, DM
    Elliott, SL
    Ellem, KAO
    Schmidt, CW
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (06) : 387 - 395
  • [50] Phase I trial of interferon γ retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma
    Nemunaitis, J
    Fong, T
    Burrows, F
    Bruce, J
    Peters, G
    Ognoskie, N
    Meyer, W
    Wynne, D
    Kerr, R
    Pippen, J
    Oldham, F
    Ando, D
    HUMAN GENE THERAPY, 1999, 10 (08) : 1289 - 1298
12345